Trading Signals: ATRA Stock Price Prediction and Forecast (Mon. Oct. 26, 2015 - Wed. Sep. 14, 2022)(Atara Biotherapeutics, Inc.)
| ATRA latest price $22.1900 (-2.68%) ($21.6000 - $23.4000) on Tue. Aug. 23, 2016. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 3.18% (three month average) | RSI | 34 | Latest Price | $22.1900(-2.68%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | ATRA declines -0.1% a day on average for past five trading days. | Weekly Trend | ATRA declines -2.7% a week on average for past two weeks. | Market Behavior | Normal for large cap. Broad based rally for small cap. | Correlated ETFs | Broad market will support ATRA advance at 0% a week (0% probability) XBI(57%) IBB(51%) ARKG(50%) IWO(47%) ARKK(45%) | Factors Impacting ATRA price | ATRA will decline at least -1.59% in a week (0% probabilities). VIXM(-16%) TLT(-13%) UUP(-10%) UNG(-3%) IPO(-3%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.59% (StdDev 3.18%) | Hourly BBV | 0 () | Intraday Trend | -3.9% | | | |
|
Resistance Level | $22.99 | 5 Day Moving Average | $22.47(-1.25%) | 10 Day Moving Average | $22.11(0.36%) | 20 Day Moving Average | $22.99(-3.48%) | To recent high | -10.8% | To recent low | 27.8% | Market Cap | $1.649b | | | | Atara Biotherapeutics, Inc. operates as a clinical stage company, which engages in the development of novel therapeutics for patients with cancer, autoimmune, and viral diseases. Its pipeline includes Tab-cel, ATA188, ATA2271/ATA3271, and ATA3219. The company was founded by Isaac E. Ciechanover on August 22, 2012 and is headquartered in South San Francisco, CA. |